QUILT-3.032: Complete Responses to N-803 Plus BCG | GU Oncology Now
Drs. Chang, Joyce take a look at QUILT-3.032, including complete responses to N-803 plus BCG in BCG-unresponsive bladder CIS.
Related Articles
Top News, Latest headlines, Latest News, World News & U.S News – UPI.com
UPI delivers the latest headlines from around the world: Top News, Entertainment, Health, Business, Science and Sports News – United Press International
Single digit micronychia in an infant
A two-month-old male presented to dermatology clinic for evaluation of nail dystrophy of the left second fingernail noted at birth. He was a full-term newborn…
Prothena Announces Phase 3 AFFIRM-AL Clinical Trial for Birtamimab in Patients with AL Amyloidosis Did Not Meet Primary Endpoint
Birtamimab did not meet the primary endpoint of time to all-cause mortality or the secondary endpoints Birtamimab development will be discontinued, including stopping the open…
Making resistance futile: lessons from the fields – SOHO Insider
In this editorial, SOHO Insider Associate Editor Dr. Jerry Radich draws a parallel between cancer treatment and agricultural pest control.
Replacing animal products with plant-based foods leads to weight loss in people with type 1 diabetes, finds new research
Replacing animal products with plant-based foods—even those defined as “unhealthy” by the plant-based diet index—is an effective strategy for weight loss in adults with type…
Phase 3 IMforte Trial Meets Primary Endpoints of OS and PFS in Extensive-Stage SCLC
The phase 3 IMforte trial has met its primary endpoints of OS and PFS, demonstrating a “clinically meaningful benefit” of lurbinectedin plus atezolizumab as first-line…
Ischemic Heart Disease in Liver Transplant Candidates With High Bleeding Risk: Any Way Out?
AbstractCoronary artery disease in candidates for liver transplantation is a real challenge because of the need to balance the risks of bleeding and thrombosis. Antiplatelet…
Is Plasma Mannose-Binding Lectin a Clue to Higher VTE Risk? | Docwire News
Investigation of a HUNT Study cohort found elevated plasma MBL levels to be associated with increased risk for future VTE.
Program Guide – ASCO Meeting Program Guide
Peter Voorhees Atrium Health / Levine Cancer Institute, Wake Forest University School of Medicine, Charlotte, NC Peter Voorhees, Tom Martin, Yi Lin, Adam Cohen, Noopur…
Subscribe | Blood Cancers Today
Sign up for Blood Cancers Today eNewsletters to join an extensive community of hematologic oncology professionals and get the latest news and insights from the…
